Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Genesco Reports Second Quarter Fiscal 2026 Results

Genesco Inc. filed a current report on September 3, 2026, disclosing second fiscal quarter results for the period ended August 1, 2026, via a press release and slide presentation furnished as exhibits.

Manish Choudhary | 03 September 2026

Equity Bancshares to Acquire Lincoln Bancorp in Stock-and-Cash Deal

Equity Bancshares, Inc. filed an 8-K with the SEC on September 3, 2026, disclosing that on September 2, 2026, it entered into an Agreement and Plan of Reorganization to acquire Lincoln Bancorp, an Iowa corporation and parent of Lincoln Savings Bank, in a transaction …

Nitish Kishor | 03 September 2026

FDA Grants Fast Track to Liquidia's YUTREPIA for Raynaud's

Liquidia Corporation filed a current report on September 3, 2026, disclosing that the U.S. Food and Drug Administration has granted Fast Track Designation to YUTREPIA (treprostinil) inhalation powder for the treatment of Raynaud's phenomenon associated with systemic sclerosis.

Vinay Lochav | 03 September 2026

Hillman Solutions Closes Kanebridge Acquisition for $315 Million

Hillman Solutions Corp. filed a Form 8-K on September 3, 2026, disclosing the August 28, 2026 completion of its acquisition of Kanebridge, LLC for an aggregate purchase price of approximately $315 million, along with a related $200.0 million term loan amendment.

Manish Choudhary | 03 September 2026

Climb Bio Reports Phase 1 Results for CLYM116 in IgA Nephropathy

Climb Bio, Inc. filed a Form 8-K with the SEC on September 3, 2026, disclosing positive results from its ongoing Phase 1 trial of CLYM116 and providing a strategy update for development in IgA nephropathy.

Manish Choudhary | 03 September 2026

LB Pharmaceuticals Appoints Joseph M. Miller as CFO

LB Pharmaceuticals Inc filed a Form 8-K on September 3, 2026, disclosing the appointment of Joseph M. Miller as Chief Financial Officer, effective September 2, 2026.

Vinay Lochav | 03 September 2026

NVIDIA to Acquire Hugging Face for $11.9 Billion

NVIDIA Corporation filed a Form 8-K on September 3, 2026, disclosing that it entered into a definitive agreement on September 2, 2026, to acquire Hugging Face, Inc., an open-source AI platform and community operator.

Nitish Kishor | 03 September 2026

AbbVie Completes Acquisition of Apogee Therapeutics

AbbVie Inc. filed a Form 8-K with the SEC on September 3, 2026, disclosing under Item 7.01 (Regulation FD) the completion of its acquisition of Apogee Therapeutics, Inc., as announced in an attached press release dated the same day.

Anjali Anand | 03 September 2026

AbbVie Completes $10.9 Billion Acquisition of Apogee Therapeutics

Apogee Therapeutics, Inc. filed a Form 8-K on September 3, 2026, reporting the completion of its merger with a wholly owned subsidiary of AbbVie Inc., making Apogee an indirect wholly owned subsidiary of AbbVie at a total equity value of approximately $10.9 billion.

Aditi Sarkar | 03 September 2026

CarGurus Names Matthew Mandel as New CFO

CarGurus, Inc. filed an 8-K with the SEC on September 3, 2026, disclosing the appointment of Matthew Mandel as Chief Financial Officer, principal financial officer, and principal accounting officer, effective October 19, 2026.

Manish Choudhary | 03 September 2026
Support

Hi! How can we help you today?

Loading…